Delisting riskPopularity #5,132
Intensity Therapeutics (INTS)
Develops INT230-6, a tumor-injection treatment candidate for solid cancers.
$4.18
vs last close+0.17 (+4.11%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 43.24% | 1.17M shares | |
|---|---|---|---|
| 18 holders · as of Jun 30, 2026 | |||
| Insiders | 4.73% | 127.9K shares | |
| 3 holders · as of Jul 1, 2026 | |||
| Other | 52.03% | 1.41M shares | |
| remainder | |||
2.70M company shares as of Sep 7, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (3.26M in the company's Sep 23, 2026 report, 2.70M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
18 holders · 1.17M shares · 5 new positions · 9 increased · 2 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| KMT Wealth Management, LLC | 496.5K | 18.37% | +496.5Knew | Aug 5, 2026 |
| Kingsbury Capital Investment Advisors LLC | 496.5K | 18.37% | +458.4K | Aug 25, 2026 |
| Sentinus, LLC | 26.7K | 0.99% | +3.4K | Aug 11, 2026 |
| Vanguard Capital Management LLC | 26.6K | 0.98% | +9.7K | Aug 13, 2026 |
| Sapient Capital LLC | 26.0K | 0.96% | 0 | Jul 9, 2026 |
| Nano Cap New Millennium Growth Fund L P | 25.0K | 0.92% | 0 | Aug 14, 2026 |
| Geode Capital Management, LLC | 22.8K | 0.84% | −3.2K | Aug 12, 2026 |
| FNY Investment Advisers, LLC | 22.0K | 0.81% | +22.0Knew | Jul 8, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.